» Articles » PMID: 37325619

Keratinocytes Use FPR2 to Detect and Initiate Antimicrobial Skin Defense

Overview
Journal Front Immunol
Date 2023 Jun 16
PMID 37325619
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Keratinocytes form a multilayer barrier that protects the skin from invaders or injuries. The barrier function of keratinocytes is in part mediated by the production of inflammatory modulators that promote immune responses and wound healing. Skin commensals and pathogens such as secrete high amounts of phenol-soluble modulin (PSM) peptides, agonists of formyl-peptide receptor 2 (FPR2). FPR2 is crucial for the recruitment of neutrophils to the sites of infection, and it can influence inflammation. FPR1 and FPR2 are also expressed by keratinocytes but the consequences of FPR activation in skin cells have remained unknown.

Methods: Since an inflammatory environment influences colonization, e. g. in patients with atopic dermatitis (AD), we hypothesized that interference with FPRs may alter keratinocyte-induced inflammation, proliferation, and bacterial colonization of the skin. To assess this hypothesis, we investigated the effects of FPR activation and inhibition in keratinocytes with respect to chemokine and cytokine release as well as proliferation and skin wound gap closure.

Results: We observed that FPR activation induces the release of IL-8, IL-1α and promotes keratinocyte proliferation in a FPR-dependent manner. To elucidate the consequence of FPR modulation on skin colonization, we used an AD-simulating skin colonization mouse model using wild-type (WT) or Fpr2 mice and demonstrate that inflammation enhances the eradication of from the skin in a FPR2-dependent way. Consistently, inhibition of FPR2 in the mouse model or in human keratinocytes as well as human skin explants promoted colonization.

Discussion: Our data indicate that FPR2 ligands promote inflammation and keratinocyte proliferation in a FPR2-dependent manner, which is necessary for eliminating during skin colonization.

Citing Articles

Strategies for Survival of in Host Cells.

Xu H, Wang S, Liu X, Li M, Wang X, Chen H Int J Mol Sci. 2025; 26(2).

PMID: 39859434 PMC: 11765632. DOI: 10.3390/ijms26020720.


Resolution of Chronic Inflammation, Restoration of Epigenetic Disturbances and Correction of Dysbiosis as an Adjunctive Approach to the Treatment of Atopic Dermatitis.

Livshits G, Kalinkovich A Cells. 2024; 13(22).

PMID: 39594647 PMC: 11593003. DOI: 10.3390/cells13221899.


Virulence Mechanisms of Staphylococcal Animal Pathogens.

Cheung G, Otto M Int J Mol Sci. 2023; 24(19).

PMID: 37834035 PMC: 10572719. DOI: 10.3390/ijms241914587.


Looking beyond Self-Protection: The Eyes Instruct Systemic Immune Tolerance Early in Life.

Villafan H, Gutierrez-Ospina G Brain Sci. 2023; 13(9).

PMID: 37759864 PMC: 10526493. DOI: 10.3390/brainsci13091261.

References
1.
Suarez-Arnedo A, Torres Figueroa F, Clavijo C, Arbelaez P, Cruz J, Munoz-Camargo C . An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays. PLoS One. 2020; 15(7):e0232565. PMC: 7386569. DOI: 10.1371/journal.pone.0232565. View

2.
Yu N, Zhang S, Lu J, Li Y, Yi X, Tang L . Serum amyloid A, an acute phase protein, stimulates proliferative and proinflammatory responses of keratinocytes. Cell Prolif. 2016; 50(3). PMC: 6529107. DOI: 10.1111/cpr.12320. View

3.
Leung D . Infection in atopic dermatitis. Curr Opin Pediatr. 2003; 15(4):399-404. DOI: 10.1097/00008480-200308000-00008. View

4.
Chung E, Luo C, Thio C, Chang Y . Immunomodulatory Role of in Atopic Dermatitis. Pathogens. 2022; 11(4). PMC: 9025081. DOI: 10.3390/pathogens11040422. View

5.
de Haas C, Veldkamp K, Peschel A, Weerkamp F, van Wamel W, Heezius E . Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med. 2004; 199(5):687-95. PMC: 2213298. DOI: 10.1084/jem.20031636. View